Key facts
- This page summarizes Waqaas Al-Siddiq's Form 4 filing for BIOTRICITY INC. (BTCY).
- 3 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 14 Mar 2023, 16:26.
Waqaas Al-Siddiq - 12 Mar 2023 Form 4 Insider Report for BIOTRICITY INC. (BTCY)
- Reporting relationship
- President, CEO and Chairman, Director
- Issuer ticker
- BTCY
- Reported as of
- 12 Mar 2023
- Net transaction value
- $0
- Reporting owner signature
- /s/ Waqaas Al-Siddiq
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Waqaas Al-Siddiq filed Form 4 for BIOTRICITY INC. (BTCY) on 14 Mar 2023.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BTCY
transaction
Derivative
Option (right to purchase)
Award
- Transaction value
- $0
- Shares
- +350,000
- Change %
- +11%
- Price
- $0.000000
- Shares after
- 3,549,984
- Date
- 12 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 350,000
- Exercise price
- $1.25
- Footnotes
- F1
BTCY
transaction
Derivative
Option (right to purchase)
Award
- Transaction value
- $0
- Shares
- +350,000
- Change %
- +9.9%
- Price
- $0.000000
- Shares after
- 3,899,984
- Date
- 12 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 350,000
- Exercise price
- $1.75
- Footnotes
- F1
BTCY
transaction
Derivative
Option (right to purchase)
Award
- Transaction value
- $0
- Shares
- +1,000,000
- Change %
- +26%
- Price
- $0.000000
- Shares after
- 4,899,984
- Date
- 12 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,000,000
- Exercise price
- $0.8100
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Granted pursuant to the 2016 Equity Incentive Plan, with 175,000 of the Option vested January 27, 2023, and the remaining unvested Option of 175,000 will vest on January 27, 2024.
Footnote F2
Granted pursuant to the 2016 Equity Incentive Plan, with 250,000 of the Option vested January 27, 2023, and the remaining unvested Option of 20,833 will become vested and exercisable every month thereafter starting on February 27, 2023, until the Option is 100% vested.